Key Segmentation
By Drug Class Type
- Anti-inflammatory
- Antihyperglycemics
- NSAIDs
- Interferons
- Others
By Indication
- Rheumatic Disease
- Type 1 Diabetes
- Multiple Sclerosis
- Inflammatory Bowel Disease
- Other Indications
By Therapeutic Application
- Disease Progression Alteration
- Immune System Modulation
- Pain Management
- Reduction of Inflammation
By Sales Channel
- Hospital Pharmacy
- Drug Store & Retail Pharmacy
- Online Store
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g. Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
By indication, rheumatic disease dominated with a 36.52% share in 2025.
North America led the market in 2025.
The rising prevalence of autoimmune disorders, including rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and inflammatory bowel disease, driven by genetic, environmental, and lifestyle factors, is the major growth driver.
The Autoimmune Disease Therapeutics Market was valued at USD 80.54 Billion in 2025.
The Autoimmune Disease Therapeutics Market is projected to grow at a CAGR of 5.52% from 2026 to 2035.